By Caroline Peachey (European Pharmaceutical Review)2023-12-15T12:39:05
The facility in Athlone, Ireland, will give Novo Nordisk additional capacity to manufacture oral products.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-29T14:00:00Z 2026-04-29T15:00:00Z
Sponsored by USP
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2025-07-16T11:00:00
Sponsored by USP
2025-09-24T15:24:00
Sponsored by Lonza
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
Site powered by Webvision Cloud